DEF 14A: MGO Global Seeks Stockholder Approval for Warrant Exercise to Comply with Nasdaq Listing Rules

MGO Global Inc. is holding a special meeting to seek stockholder approval for the exercisability of common stock purchase warrants and the issuance of underlying shares to comply with Nasdaq Listing Rule 5635(d).

Summary

• MGO Global Inc. is convening a Special Meeting of Stockholders on January 24, 2025, to vote on a proposal related to warrant exercises.
• The primary purpose of the meeting is to obtain stockholder approval, as required by Nasdaq Listing Rule 5635(d), for the exercisability of common stock purchase warrants issued in connection with a securities offering on December 24, 2024.
• The proposal involves the potential issuance of up to 94,725,000 shares of common stock underlying these warrants.
• The Board of Directors recommends a vote FOR the Warrant Exercise Proposal.
• The record date for determining stockholders eligible to vote at the Special Meeting was December 13, 2024.
• The meeting will be held in person at the company's Fort Lauderdale, Florida location.
• A quorum of 33 1/3% of the outstanding shares of stock entitled to vote must be present or represented by proxy to conduct the meeting.
• The company is providing proxy materials to stockholders via mail and electronically at www.proxyvote.com.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily focused on procedural matters related to the Special Meeting and the Warrant Exercise Proposal. The potential dilution is a concern, but the company is acting to comply with regulations.

Positives

• Approval of the Warrant Exercise Proposal will allow the company to comply with Nasdaq Listing Rule 5635(d), enabling the exercise of warrants issued in a prior offering.
• Obtaining approval at the Special Meeting will save the company time and expenses associated with holding additional meetings every 90 days until approval is obtained.
• The company is providing multiple voting options for stockholders, including mail, internet, and telephone, to ensure maximum participation.

Negatives

• The potential issuance of up to 94,725,000 shares of common stock upon warrant exercise could dilute existing stockholders' ownership.
• Failure to obtain stockholder approval will require the company to hold additional meetings every 90 days until approval is secured, incurring additional expenses.

Risks

• If the warrant exercise price is reset to the floor of $0.19 per share and the alternative cashless exercise option is used, the company will be required to issue a significant number of new shares (94,725,000), potentially diluting existing shareholders.
• Failure to secure stockholder approval for the Warrant Exercise Proposal will necessitate additional meetings and associated costs.
• The warrants are not exercisable until stockholder approval is obtained, which could impact the company's ability to raise capital through warrant exercises.

Future Outlook

The company intends to hold additional meetings every 90 days until it obtains Warrant Stockholder Approval if the Warrant Exercise Proposal is not approved at the Special Meeting.

Management Comments

• Maximiliano Ojeda, Chairman and Chief Executive Officer, expressed gratitude for stockholders' ongoing support.
• The Board of Directors has determined that the proposal is in the best interest of the Company and its stockholders and has approved such proposal.

Industry Context

The need for stockholder approval to exercise warrants is driven by Nasdaq listing rules, which aim to protect investors from excessive dilution and ensure fair pricing in securities offerings.

Comparison to Industry Standards

• The requirement for stockholder approval for warrant exercises is a common practice among Nasdaq-listed companies when the potential issuance of shares exceeds a certain threshold, typically 20% of outstanding shares.
• The specific rules and thresholds vary, but the underlying principle is to ensure that significant issuances of equity are subject to shareholder oversight.
• Comparable companies in similar situations, such as micro-cap or small-cap firms conducting private placements, often face similar requirements to obtain stockholder approval for warrant exercises to comply with Nasdaq or NYSE listing rules.

Corporate Governance

Stakeholder Impact

• Approval of the Warrant Exercise Proposal could dilute existing shareholders' ownership if the warrants are exercised.
• Failure to approve the proposal could delay the company's access to capital and require additional meetings, impacting the company's financial performance.

Next Steps

• Stockholders are urged to vote on the Warrant Exercise Proposal before the Special Meeting on January 24, 2025.
• The company will announce the final voting results of the Special Meeting on a Current Report on Form 8-K filed with the SEC within four business days after the Special Meeting.
• If the Warrant Exercise Proposal is not approved, the company will call a meeting every ninety (90) days after the Special Meeting until it obtains Warrant Stockholder Approval.

Key Dates

Keywords

Warrant Exercise, Stockholder Approval, Nasdaq Listing Rule 5635(d), Common Stock, Proxy Statement, Special Meeting, MGO Global